SYK
Stryker·NYSE
--
--(--)
--
--(--)
SYK fundamentals
Stryker (SYK) Revenue Breakdown: Q4 2025 Business & Regional Performance
Stryker (SYK) reported total revenue of 7.17B USD in Q4 2025, with its core business segment Medsurg and Neurotechnology contributing 63.62%. Regionally, United States remained the largest market, accounting for 75.88% of total revenue. Explore Stryker's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Stryker (SYK) reported total revenue of 7.17B USD in Q4 2025, with its core business segment Medsurg and Neurotechnology contributing 63.62%. Regionally, United States remained the largest market, accounting for 75.88% of total revenue. Explore Stryker's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Stryker's earnings call?What factors drove the changes in Stryker's revenue and profit?What is Stryker's latest dividend and current dividend yield?What is Stryker's gross profit margin?What does Stryker do and what are its main business segments?What guidance did Stryker's management provide for the next earnings period?What is the revenue and EPS growth rate for Stryker year over year?Did Stryker beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
